Clinical trial
First in Human of Single and Multiple Doses of MOR106
NCT02739009 is registered in ClinicalTrials.gov with Lakefront Biotherapeutics NV as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- First in Human of Single and Multiple Doses of MOR106
- Lead sponsor
- Lakefront Biotherapeutics NV
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- April 30, 2016
- Completion date
- August 1, 2017
- Enrollment
- 81 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
dermatitis, atopic, healthy